SerenQ Nad+ 500mg Peptide Pen

SerenQ NAD+ 500 mg contains nicotinamide adenine dinucleotide, a naturally occurring coenzyme found in virtually every living cell. Unlike the other compounds in the SerenQ peptide range, NAD+ is not a peptide. It plays a central role in cellular energy production by helping transfer electrons during metabolic reactions.

NAD+ is also involved in several processes linked with cellular maintenance. It is used by enzymes including sirtuins and PARPs, which are studied for their roles in gene regulation, DNA repair and responses to cellular stress.

Research interest in NAD+ has grown because cellular levels can change with age and metabolic state. Much of the current science looks at how NAD+ availability relates to mitochondrial function, energy metabolism and the systems cells use to maintain and repair themselves.

Pens supplied directly from the manufacturer in sealed retail cartons, with an individual serial number and QR authenticity code for product and batch verification.

Form: Pre-filled pen

• 500 mg of NAD+ per pen

• Supplied pre-dissolved in a liquid solution

• 1 dial unit = approximately 1.67 mg NAD+

• 30 dial units = approximately 50 mg

• 300 dial units in total across the full pen

• Approximately 10 full 30-unit measurements per pen

• Graduated dial and viewing window for clear unit measurement

• 4 individually sealed 32G 0.23 × 4 mm pen tips supplied

• 4 alcohol swabs supplied

• Protective cap and rigid retail carton included

• Batch number, expiry date and serial number printed directly on the pen

• Individual QR authenticity code for product and batch verification

Handling and storage:

• Store refrigerated at 2–8°C

• Do not freeze

• Keep in the outer carton and protect from direct light

• Short periods at room temperature during transit are expected

• Keep out of reach of children and animals

• Expiry on current sealed stock: 12/2027

What is in the box:

• 1 × SerenQ NAD+ 500 mg pre-filled pen

• 4 × sealed 32G pen tips

• 4 × alcohol swabs

• 1 × serialised, QR-coded retail carton

NAD+ is widely studied in cellular and metabolic research, but direct injectable NAD+ is not an established licensed treatment. Much of the human research in this area has focused on NAD+ precursors rather than injectable NAD+ itself. SerenQ NAD+ is supplied as a research-grade material rather than an approved medicine.